Product Program year 2022 Source: CMS Open Payments

Trulign IOL

Device Ophthalmology

PDI 10757770521514

Open in the dashboard

General payments

$532,506

1,665 payments

Research payments

$0

0 payments

Through program year 2022, $532,506 in general payments and $0 in research payments were reported against Trulign IOL (Ophthalmology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2022 General $304,739 882
2021 General $227,767 783

Breakdown

Who paid General payments · program years 2021–2022
  1. Bausch & Lomb Americas Inc. $304,739 882 payments
  2. Bausch & Lomb, a division of Bausch Health US, LLC $227,751 780 payments
  3. Salix Pharmaceuticals, a division of Bausch Health US, LLC $16 3 payments
Top recipients General payments · program year 2022
  1. Robert Weinstock Ophthalmology · Largo, FL $23,829 8% · 20 payments
  2. Steven Silverstein Ophthalmology · Kansas City, MO $19,675 6% · 35 payments
  3. Neel Desai Ophthalmology · Largo, FL $19,601 6% · 13 payments
  4. Timothy Page Ophthalmology · Birmingham, MI $19,260 6% · 26 payments
  5. Inder Singh Ophthalmology · Racine, WI $19,184 6% · 29 payments

The top 5 of 72 recipients; each share is of general payments naming this product in 2022.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2022
  1. Ophthalmology $268,213 94% · 38 practitioners
  2. Cornea and External Diseases Specialist Ophthalmology $7,417 3% · 2 practitioners
  3. Retina Specialist Ophthalmology $4,513 2% · 2 practitioners
  4. Internal Medicine $2,463 <1% · 2 practitioners
  5. Neuro-ophthalmology Ophthalmology $2,284 <1% · 1 practitioner

The top 5 of 13 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2022
  1. Florida $61,554 20% · 4 recipients
  2. Illinois $30,721 10% · 3 recipients
  3. California $29,620 10% · 3 recipients
  4. Michigan $24,547 8% · 3 recipients
  5. Missouri $22,738 7% · 2 recipients

The top 5 of 24 states; each share is of general payments naming this product in 2022 where a state was reported.

The top 25 states, free in the app

1,665 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record